Global Heart-on-a-chip

Heart-on-a-chip Comprehensive Study by Type (Children Heart-on-a-chip, Adult Heart-on-a-chip), Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users) Players and Region - Global Market Outlook to 2030

Heart-on-a-chip Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Heart-on-a-chip
Increasing Focus on Drug Discovery Activities will help to boost the global market in the forecasted period. A heart on a chip is a cell culturing microfluidic device to create a highly controlled environment to mimic the natural habitat of the heart cells. A heart-on-chip is a microfluidic chip reproducing the mechanisms of a heart, in order to test medicine quickly and observe the reaction of heart cells. Great care is given to mimic the mechanics of a heart in an artificial structure, lined with live heart cells. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. In 2008, there were an estimated 17.3 million deaths due to cardiovascular diseases. This means that around 30% of the people who died in 2008 died because of heart failure. Moreover, cardiotoxicity is one of the leading causes of drug withdrawals.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Heart-on-a-chip market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Mimetas (Netherlands), Emulate (United States), InSphero (Switzerland), Ascendance Bio (United States), CN Bio (United Kingdom), TissUse (Germany), Kirkstall (United Kingdom), HUREL (HUREL) (United States), SynVivo (United States) and AxoSim (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Nortis (United States).

Segmentation Overview
AMA Research has segmented the market of Global Heart-on-a-chip market by Type (Children Heart-on-a-chip and Adult Heart-on-a-chip), Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Other End Users) and Region.



On the basis of geography, the market of Heart-on-a-chip has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement.

Influencing Trend:
Technological Advancements and New Products Launches and Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Heart-on-Chips Manufacturers

Market Growth Drivers:
Significant Increase in Research Funding and Venture Capital Investments for the Development of Heart-on-Chips

Challenges:
The complexity of Organs-on-Chips Models and The dearth of Skilled Professionals

Restraints:
Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows

Opportunities:
Increasing Focus on Drug Discovery Activities and Application of Heart-on-Chips in Oncology Research

In February 2024, NIST has developed a system that mimics humanlike models for studying cardiovascular disease. Heart-on-a-chip aligns with national efforts to move away from animal testing in drug development. The organ-on-a-chip suite, which includes heart-on-a-chip, helps ensure safer, faster and more precise drug development.


Key Target Audience
Government Regulatory Bodies, Government research Organization, Private Research Organization and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Children Heart-on-a-chip
  • Adult Heart-on-a-chip
By Application
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Other End Users
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Significant Increase in Research Funding and Venture Capital Investments for the Development of Heart-on-Chips
    • 3.3. Market Challenges
      • 3.3.1. The complexity of Organs-on-Chips Models
      • 3.3.2. The dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements and New Products Launches
      • 3.4.2. Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Heart-on-Chips Manufacturers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Heart-on-a-chip, by Type, Application and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Heart-on-a-chip (Value)
      • 5.2.1. Global Heart-on-a-chip by: Type (Value)
        • 5.2.1.1. Children Heart-on-a-chip
        • 5.2.1.2. Adult Heart-on-a-chip
      • 5.2.2. Global Heart-on-a-chip by: Application (Value)
        • 5.2.2.1. Pharmaceutical & Biotechnology Companies
        • 5.2.2.2. Academic & Research Institutes
        • 5.2.2.3. Other End Users
      • 5.2.3. Global Heart-on-a-chip Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Heart-on-a-chip (Price)
      • 5.3.1. Global Heart-on-a-chip by: Type (Price)
  • 6. Heart-on-a-chip: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mimetas (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Emulate (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. InSphero (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ascendance Bio (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CN Bio (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. TissUse (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Kirkstall (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HUREL (HUREL) (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SynVivo (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AxoSim (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Heart-on-a-chip Sale, by Type, Application and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Heart-on-a-chip (Value)
      • 7.2.1. Global Heart-on-a-chip by: Type (Value)
        • 7.2.1.1. Children Heart-on-a-chip
        • 7.2.1.2. Adult Heart-on-a-chip
      • 7.2.2. Global Heart-on-a-chip by: Application (Value)
        • 7.2.2.1. Pharmaceutical & Biotechnology Companies
        • 7.2.2.2. Academic & Research Institutes
        • 7.2.2.3. Other End Users
      • 7.2.3. Global Heart-on-a-chip Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Heart-on-a-chip (Price)
      • 7.3.1. Global Heart-on-a-chip by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Heart-on-a-chip: by Type(USD Million)
  • Table 2. Heart-on-a-chip Children Heart-on-a-chip , by Region USD Million (2018-2023)
  • Table 3. Heart-on-a-chip Adult Heart-on-a-chip , by Region USD Million (2018-2023)
  • Table 4. Heart-on-a-chip: by Application(USD Million)
  • Table 5. Heart-on-a-chip Pharmaceutical & Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 6. Heart-on-a-chip Academic & Research Institutes , by Region USD Million (2018-2023)
  • Table 7. Heart-on-a-chip Other End Users , by Region USD Million (2018-2023)
  • Table 8. South America Heart-on-a-chip, by Country USD Million (2018-2023)
  • Table 9. South America Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 10. South America Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 11. Brazil Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 12. Brazil Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 13. Argentina Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 14. Argentina Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 15. Rest of South America Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Heart-on-a-chip, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 20. China Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 21. China Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 22. Japan Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 23. Japan Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 24. India Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 25. India Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 26. South Korea Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 27. South Korea Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 28. Taiwan Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 29. Taiwan Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 30. Australia Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 31. Australia Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 34. Europe Heart-on-a-chip, by Country USD Million (2018-2023)
  • Table 35. Europe Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 36. Europe Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 37. Germany Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 38. Germany Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 39. France Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 40. France Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 41. Italy Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 42. Italy Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 43. United Kingdom Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 45. Netherlands Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 46. Netherlands Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 49. MEA Heart-on-a-chip, by Country USD Million (2018-2023)
  • Table 50. MEA Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 51. MEA Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 52. Middle East Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 53. Middle East Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 54. Africa Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 55. Africa Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 56. North America Heart-on-a-chip, by Country USD Million (2018-2023)
  • Table 57. North America Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 58. North America Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 59. United States Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 60. United States Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 61. Canada Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 62. Canada Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 63. Mexico Heart-on-a-chip, by Type USD Million (2018-2023)
  • Table 64. Mexico Heart-on-a-chip, by Application USD Million (2018-2023)
  • Table 65. Heart-on-a-chip: by Type(USD/Units)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Heart-on-a-chip: by Type(USD Million)
  • Table 77. Heart-on-a-chip Children Heart-on-a-chip , by Region USD Million (2025-2030)
  • Table 78. Heart-on-a-chip Adult Heart-on-a-chip , by Region USD Million (2025-2030)
  • Table 79. Heart-on-a-chip: by Application(USD Million)
  • Table 80. Heart-on-a-chip Pharmaceutical & Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 81. Heart-on-a-chip Academic & Research Institutes , by Region USD Million (2025-2030)
  • Table 82. Heart-on-a-chip Other End Users , by Region USD Million (2025-2030)
  • Table 83. South America Heart-on-a-chip, by Country USD Million (2025-2030)
  • Table 84. South America Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 85. South America Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 86. Brazil Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 87. Brazil Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 88. Argentina Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 89. Argentina Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 90. Rest of South America Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 91. Rest of South America Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 92. Asia Pacific Heart-on-a-chip, by Country USD Million (2025-2030)
  • Table 93. Asia Pacific Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 94. Asia Pacific Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 95. China Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 96. China Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 97. Japan Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 98. Japan Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 99. India Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 100. India Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 101. South Korea Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 102. South Korea Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 103. Taiwan Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 104. Taiwan Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 105. Australia Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 106. Australia Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 108. Rest of Asia-Pacific Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 109. Europe Heart-on-a-chip, by Country USD Million (2025-2030)
  • Table 110. Europe Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 111. Europe Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 112. Germany Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 113. Germany Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 114. France Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 115. France Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 116. Italy Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 117. Italy Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 118. United Kingdom Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 119. United Kingdom Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 120. Netherlands Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 121. Netherlands Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 122. Rest of Europe Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 123. Rest of Europe Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 124. MEA Heart-on-a-chip, by Country USD Million (2025-2030)
  • Table 125. MEA Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 126. MEA Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 127. Middle East Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 128. Middle East Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 129. Africa Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 130. Africa Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 131. North America Heart-on-a-chip, by Country USD Million (2025-2030)
  • Table 132. North America Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 133. North America Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 134. United States Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 135. United States Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 136. Canada Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 137. Canada Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 138. Mexico Heart-on-a-chip, by Type USD Million (2025-2030)
  • Table 139. Mexico Heart-on-a-chip, by Application USD Million (2025-2030)
  • Table 140. Heart-on-a-chip: by Type(USD/Units)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Heart-on-a-chip: by Type USD Million (2018-2023)
  • Figure 5. Global Heart-on-a-chip: by Application USD Million (2018-2023)
  • Figure 6. South America Heart-on-a-chip Share (%), by Country
  • Figure 7. Asia Pacific Heart-on-a-chip Share (%), by Country
  • Figure 8. Europe Heart-on-a-chip Share (%), by Country
  • Figure 9. MEA Heart-on-a-chip Share (%), by Country
  • Figure 10. North America Heart-on-a-chip Share (%), by Country
  • Figure 11. Global Heart-on-a-chip: by Type USD/Units (2018-2023)
  • Figure 12. Global Heart-on-a-chip share by Players 2023 (%)
  • Figure 13. Global Heart-on-a-chip share by Players (Top 3) 2023(%)
  • Figure 14. Global Heart-on-a-chip share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Mimetas (Netherlands) Revenue, Net Income and Gross profit
  • Figure 17. Mimetas (Netherlands) Revenue: by Geography 2023
  • Figure 18. Emulate (United States) Revenue, Net Income and Gross profit
  • Figure 19. Emulate (United States) Revenue: by Geography 2023
  • Figure 20. InSphero (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. InSphero (Switzerland) Revenue: by Geography 2023
  • Figure 22. Ascendance Bio (United States) Revenue, Net Income and Gross profit
  • Figure 23. Ascendance Bio (United States) Revenue: by Geography 2023
  • Figure 24. CN Bio (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. CN Bio (United Kingdom) Revenue: by Geography 2023
  • Figure 26. TissUse (Germany) Revenue, Net Income and Gross profit
  • Figure 27. TissUse (Germany) Revenue: by Geography 2023
  • Figure 28. Kirkstall (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Kirkstall (United Kingdom) Revenue: by Geography 2023
  • Figure 30. HUREL (HUREL) (United States) Revenue, Net Income and Gross profit
  • Figure 31. HUREL (HUREL) (United States) Revenue: by Geography 2023
  • Figure 32. SynVivo (United States) Revenue, Net Income and Gross profit
  • Figure 33. SynVivo (United States) Revenue: by Geography 2023
  • Figure 34. AxoSim (United States) Revenue, Net Income and Gross profit
  • Figure 35. AxoSim (United States) Revenue: by Geography 2023
  • Figure 36. Global Heart-on-a-chip: by Type USD Million (2025-2030)
  • Figure 37. Global Heart-on-a-chip: by Application USD Million (2025-2030)
  • Figure 38. South America Heart-on-a-chip Share (%), by Country
  • Figure 39. Asia Pacific Heart-on-a-chip Share (%), by Country
  • Figure 40. Europe Heart-on-a-chip Share (%), by Country
  • Figure 41. MEA Heart-on-a-chip Share (%), by Country
  • Figure 42. North America Heart-on-a-chip Share (%), by Country
  • Figure 43. Global Heart-on-a-chip: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Mimetas (Netherlands)
  • Emulate (United States)
  • InSphero (Switzerland)
  • Ascendance Bio (United States)
  • CN Bio (United Kingdom)
  • TissUse (Germany)
  • Kirkstall (United Kingdom)
  • HUREL (HUREL) (United States)
  • SynVivo (United States)
  • AxoSim (United States)
Additional players considered in the study are as follows:
Nortis (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 244 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Heart-on-a-chip Quantitative research analysis
Global Heart-on-a-chip Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Mimetas (Netherlands), Emulate (United States), InSphero (Switzerland), Ascendance Bio (United States), CN Bio (United Kingdom), TissUse (Germany), Kirkstall (United Kingdom), HUREL (HUREL) (United States), SynVivo (United States) and AxoSim (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements and New Products Launches " is seen as one of major influencing trends for Heart-on-a-chip Market during projected period 2023-2030.
The Heart-on-a-chip market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Heart-on-a-chip Report?

Have a Query? Click Here

Other Related Reports

Nuclear Medicine Preclinical Imaging Equipment Comprehensive Study by Application (Oncology, Cardiology, Neurology, Thyroid), Diagnostics (SPECT (Standalone, SPECT/CT System, SPECT/MRI System), PET (...
$ 3750
Smart Home Healthcare Comprehensive Study by Application (Fall Prevention and Detection, Health Status Monitoring, Nutrition and Diet Monitoring, Memory Aids, Others), Technology (Wired, Wireless), S...
$ 3450
Preclinical Molecular Imaging Comprehensive Study by Type (Equipment/Device, Reagents and Imaging Agents, Service), Equipment Type (MRI, MPI, Ultrasound, Preclinical Nuclear Imaging Systems (SPECT, ...
$ 3750
Chemotherapy Comprehensive Study by Type (Alkylating Agents, Anti-metabolites, Plant Alkaloids and Terpenoids, Podophyllotoxin, Taxanes, Topoisomerase Inhibitor, Anti-Tumour Antibiotics, Hormones, Mo...
$ 3750
Prostate Cancer Nuclear Medicine Diagnostics Comprehensive Study by Type (Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), Application (Hospitals, Clinics, Oth...
$ 3800
Smart Medicine Bottles Comprehensive Study by Type (Smart Pill Boxes, Smart Pill Bottles, Others), Indication (Dementia, Cancer Management, Diabetes Care, Others), End Use (Home Care Settings, Specia...
$ 3450